Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors.

Hendriks Y, Franken P, Dierssen JW, De Leeuw W, Wijnen J, Dreef E, Tops C, Breuning M, Bröcker-Vriends A, Vasen H, Fodde R, Morreau H.

Am J Pathol. 2003 Feb;162(2):469-77.

2.

EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer.

Jagmohan-Changur S, Poikonen T, Vilkki S, Launonen V, Wikman F, Orntoft TF, Møller P, Vasen H, Tops C, Kolodner RD, Mecklin JP, Järvinen H, Bevan S, Houlston RS, Aaltonen LA, Fodde R, Wijnen J, Karhu A.

Cancer Res. 2003 Jan 1;63(1):154-8.

3.

The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.

Foulkes WD, Thiffault I, Gruber SB, Horwitz M, Hamel N, Lee C, Shia J, Markowitz A, Figer A, Friedman E, Farber D, Greenwood CM, Bonner JD, Nafa K, Walsh T, Marcus V, Tomsho L, Gebert J, Macrae FA, Gaff CL, Paillerets BB, Gregersen PK, Weitzel JN, Gordon PH, MacNamara E, King MC, Hampel H, De La Chapelle A, Boyd J, Offit K, Rennert G, Chong G, Ellis NA.

Am J Hum Genet. 2002 Dec;71(6):1395-412. Epub 2002 Nov 26.

4.

A 10-Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred.

Wagner A, van der Klift H, Franken P, Wijnen J, Breukel C, Bezrookove V, Smits R, Kinarsky Y, Barrows A, Franklin B, Lynch J, Lynch H, Fodde R.

Genes Chromosomes Cancer. 2002 Sep;35(1):49-57.

PMID:
12203789
5.

Allele separation facilitates interpretation of potential splicing alterations and genomic rearrangements.

Nakagawa H, Yan H, Lockman J, Hampel H, Kinzler KW, Vogelstein B, De La Chapelle A.

Cancer Res. 2002 Aug 15;62(16):4579-82.

6.

Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.

Wahlberg SS, Schmeits J, Thomas G, Loda M, Garber J, Syngal S, Kolodner RD, Fox E.

Cancer Res. 2002 Jun 15;62(12):3485-92.

7.

Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.

Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen GM, Walsh MD, Leggett BA, Young JP, Barker MA, Jass JR, Hopper J, Gallinger S, Bapat B, Redston M, Thibodeau SN.

J Clin Oncol. 2002 Feb 15;20(4):1043-8.

PMID:
11844828
8.

MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.

Charbonnier F, Olschwang S, Wang Q, Boisson C, Martin C, Buisine MP, Puisieux A, Frebourg T.

Cancer Res. 2002 Feb 1;62(3):848-53.

9.

Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait.

Halford S, Sasieni P, Rowan A, Wasan H, Bodmer W, Talbot I, Hawkins N, Ward R, Tomlinson I.

Cancer Res. 2002 Jan 1;62(1):53-7.

11.

Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system.

Trojan J, Zeuzem S, Randolph A, Hemmerle C, Brieger A, Raedle J, Plotz G, Jiricny J, Marra G.

Gastroenterology. 2002 Jan;122(1):211-9.

PMID:
11781295
12.

The role of hPMS1 and hPMS2 in predisposing to colorectal cancer.

Liu T, Yan H, Kuismanen S, Percesepe A, Bisgaard ML, Pedroni M, Benatti P, Kinzler KW, Vogelstein B, Ponz de Leon M, Peltomäki P, Lindblom A.

Cancer Res. 2001 Nov 1;61(21):7798-802.

13.

A role for MLH3 in hereditary nonpolyposis colorectal cancer.

Wu Y, Berends MJ, Sijmons RH, Mensink RG, Verlind E, Kooi KA, van der Sluis T, Kempinga C, van dDer Zee AG, Hollema H, Buys CH, Kleibeuker JH, Hofstra RM.

Nat Genet. 2001 Oct;29(2):137-8.

PMID:
11586295
14.

A nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families.

Stella A, Wagner A, Shito K, Lipkin SM, Watson P, Guanti G, Lynch HT, Fodde R, Liu B.

Cancer Res. 2001 Oct 1;61(19):7020-4.

15.
16.

AGA technical review on hereditary colorectal cancer and genetic testing.

Giardiello FM, Brensinger JD, Petersen GM.

Gastroenterology. 2001 Jul;121(1):198-213. Review.

PMID:
11438509
17.

Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms.

Wu Y, Berends MJ, Post JG, Mensink RG, Verlind E, Van Der Sluis T, Kempinga C, Sijmons RH, van der Zee AG, Hollema H, Kleibeuker JH, Buys CH, Hofstra RM.

Gastroenterology. 2001 Jun;120(7):1580-7.

PMID:
11375940
18.

Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree.

Wagner A, Hendriks Y, Meijers-Heijboer EJ, de Leeuw WJ, Morreau H, Hofstra R, Tops C, Bik E, Bröcker-Vriends AH, van Der Meer C, Lindhout D, Vasen HF, Breuning MH, Cornelisse CJ, van Krimpen C, Niermeijer MF, Zwinderman AH, Wijnen J, Fodde R.

J Med Genet. 2001 May;38(5):318-22.

19.

Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.

de Leeuw WJ, Dierssen J, Vasen HF, Wijnen JT, Kenter GG, Meijers-Heijboer H, Brocker-Vriends A, Stormorken A, Moller P, Menko F, Cornelisse CJ, Morreau H.

J Pathol. 2000 Nov;192(3):328-35.

PMID:
11054716
20.

Two common forms of the human MLH1 gene may be associated with functional differences.

Hutter P, Couturier A, Rey-Berthod C.

J Med Genet. 2000 Oct;37(10):776-81. No abstract available.

Supplemental Content

Support Center